# Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients [Letter]
> Syahruddin F.I.

URL kanonis: https://discover.unhas.ac.id/publications/pub_scopus_85191357027
Jurnal / Konferensi: Breast Cancer Targets and Therapy
Tahun terbit: 2024
DOI: https://doi.org/10.2147/BCTT.S472589
ISSN: 11791314
Kuartil SJR: Q2
Citations: 0

## Authors
- Syahruddin F.I.

## Abstract
Febie Irsandy Syahruddin,1 Prihantono,2 Mirna Muis3 1Department of Radiology, Faculty of Medicine, Universitas Muslim Indonesia, Makassar, Indonesia; 2Department of Surgery, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia; 3Department of Radiology, Faculty of Medicine, Hasanuddin University, Makassar, IndonesiaCorrespondence: Febie Irsandy Syahruddin, Department of Radiology, Faculty of Medicine, Universitas Muslim Indoensia, Urip Sumoharjo Road KM 05, Makassar, Indonesia, Email febie.irsandysy@umi.ac.id

## Keywords
- Medicine
- Surgical oncology
- Breast cancer
- Oncology
- Internal medicine
- Cancer
- Trastuzumab

---
Sumber: Discover Unhas — RIMS Universitas Hasanuddin.
Saat mengutip, gunakan DOI bila tersedia atau URL kanonis di atas.